# PTRH1

## Overview
PTRH1 is a gene that encodes the protein peptidyl-tRNA hydrolase 1 homolog, which plays a critical role in cellular processes by facilitating the release of tRNA from peptidyl-tRNA complexes that have prematurely terminated translation. This function is essential for maintaining protein synthesis efficiency and cellular homeostasis, as it prevents the accumulation of potentially toxic peptidyl-tRNA in the cytoplasm (Gao2023High). Beyond its primary role in translation, PTRH1 is also involved in the regulation of mRNA stability, particularly influencing the expression of PD-L1 mRNA, a key molecule in immune response regulation (Gao2023High). The protein's activity is modulated by various cellular conditions, such as high glucose levels, which can impact its expression and subsequent immune functions, especially in cancer contexts like pancreatic cancer (Gao2023High). PTRH1's involvement in these processes underscores its significance in both normal cellular function and disease states, including its potential impact on cancer progression and treatment responses.

## Function
PTRH1 (peptidyl-tRNA hydrolase 1 homolog) is a protein involved in the release of tRNA from peptidyl-tRNA complexes that have prematurely terminated translation. This function is crucial for maintaining protein synthesis efficiency and cellular homeostasis by preventing the accumulation of peptidyl-tRNA, which can be toxic to cells. PTRH1 is active in the cytoplasm, where it helps ensure the proper recycling of tRNA molecules, allowing them to be reused in subsequent rounds of protein synthesis (Gao2023High).

In addition to its role in translation, PTRH1 has been implicated in the regulation of mRNA stability. Specifically, PTRH1 acts as an RNA-binding protein that modulates the stability of PD-L1 mRNA, a key molecule involved in immune response regulation. Under high glucose conditions, PTRH1 expression is downregulated, leading to increased stability and expression of PD-L1 mRNA. This process is mediated through the RAS signaling pathway, which affects PTRH1's ability to bind to the PD-L1 mRNA 3′-UTR, thereby influencing its stability (Gao2023High). This regulatory function of PTRH1 highlights its broader role in cellular processes beyond translation, impacting immune function and potentially influencing cancer progression.

## Clinical Significance
PTRH1 has been implicated in various clinical conditions through alterations in its expression levels and interactions. In colorectal cancer (CRC), high expression of PTRH1 is associated with poor prognosis. It is part of a prognostic risk score model that includes other RNA binding proteins, and its overexpression is linked to deeper tumor infiltration in CRC patients (Zhang2020Molecular). Despite its significant role in prognosis, genetic alterations of PTRH1 are rare in CRC (Zhang2020Molecular).

In pancreatic cancer, PTRH1 plays a role in regulating PD-L1 expression, particularly under high glucose conditions. High glucose levels lead to the downregulation of PTRH1, which stabilizes PD-L1 mRNA, resulting in increased PD-L1 expression and immunosuppression in the tumor microenvironment. Overexpression of PTRH1 can counteract these effects, enhancing T cell infiltration and function, and potentially improving responses to anti-PD-L1 therapy (Gao2023High).

PTRH1 has also been identified as part of a gene panel associated with radiation resistance in colorectal cancer, although its specific role in this context is less clear (Song2023Predicting). Despite these associations, no direct diseases or conditions caused by mutations in PTRH1 have been identified in the provided context.

## Interactions
PTRH1, or peptidyl-tRNA hydrolase 1 homolog, is involved in interactions with nucleic acids, particularly in the context of regulating mRNA stability. In pancreatic cancer cells, PTRH1 has been shown to bind to the 3′-untranslated region (3′-UTR) of PD-L1 mRNA, influencing its stability and expression levels. This interaction is crucial under high glucose conditions, where PTRH1 expression is downregulated, leading to increased PD-L1 expression and subsequent suppression of T cell cytotoxic function in the tumor microenvironment (Gao2023High).

The binding of PTRH1 to PD-L1 mRNA is facilitated by a specific motif, GAA GAA AGA, located in the 3′-UTR of the mRNA. This interaction suggests a mechanism by which PTRH1 can modulate PD-L1 mRNA stability and expression, thereby impacting immune responses in pancreatic cancer (Gao2023High). The study by Gao et al. highlights the potential of PTRH1 to influence immune modulation and tumor growth suppression, particularly in high glucose environments, by interacting with pathways involved in immune response regulation (Gao2023High). However, specific protein-protein interactions involving PTRH1 are not detailed in the provided context.


## References


[1. (Song2023Predicting) Yanwei Song, Zheng Deng, Haoran Sun, Yucui Zhao, Ruyi Zhao, Jin Cheng, and Qian Huang. Predicting tumor repopulation through the gene panel derived from radiation resistant colorectal cancer cells. Journal of Translational Medicine, June 2023. URL: http://dx.doi.org/10.1186/s12967-023-04260-x, doi:10.1186/s12967-023-04260-x. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-023-04260-x)

[2. (Zhang2020Molecular) Zhen Zhang, Ling Wang, Quan Wang, Mengmeng Zhang, Bo Wang, Kewei Jiang, Yingjiang Ye, Shan Wang, and Zhanlong Shen. Molecular characterization and clinical relevance of rna binding proteins in colorectal cancer. Frontiers in Genetics, October 2020. URL: http://dx.doi.org/10.3389/fgene.2020.580149, doi:10.3389/fgene.2020.580149. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2020.580149)

[3. (Gao2023High) Chenggang Gao, Jiaoshun Chen, Jianwei Bai, Haoxiang Zhang, Yanyi Tao, Shihong Wu, Hehe Li, Heshui Wu, Qiang Shen, and Tao Yin. High glucose-upregulated pd-l1 expression through ras signaling-driven downregulation of ptrh1 leads to suppression of t cell cytotoxic function in tumor environment. Journal of Translational Medicine, July 2023. URL: http://dx.doi.org/10.1186/s12967-023-04302-4, doi:10.1186/s12967-023-04302-4. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-023-04302-4)